Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5

View source ↗

Summary

The DREAM study evaluating a phosphodiesterase-5 inhibitor for Alzheimer's medicines has completed data analysis, with results posted on 2024-02-20, in the cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• PDE5 inhibitor (phosphodiesterase-5 inhibitor) (phosphodiesterase-5 inhibitor)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED | Results posted: 2024-02-20